EGFR and glioblastoma: We envision that RIOK loss-of-function phenotypes in GBM cells are due to the combined effects of Akt inhibition and p53 induction, which together stimulate apoptosis and cell cycle exit of EGFR- and PTEN- mutant GBM cells, which share a common dependence on Akt signaling (Figure 7).